Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review
Gaetano Giuffrida, Uroš Markovic, Annalisa Condorelli, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Challenges in Gaucher disease: Perspectives from an expert panel
Gregory A. Grabowski, Priya S. Kishnani, Roy N. Alcalay, et al.
Molecular Genetics and Metabolism (2025), pp. 109074-109074
Closed Access | Times Cited: 1
The use of Ambroxol for the treatment of Gaucher disease: A systematic review
Diego Agustín Abelleyra Lastoria, S. Grewal, Derralynn Hughes
eJHaem (2024) Vol. 5, Iss. 1, pp. 206-221
Open Access | Times Cited: 6
Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease
Zuzanna Cyske, Lidia Gaffke, Estera Rintz, et al.
Neurochemistry International (2024) Vol. 178, pp. 105774-105774
Closed Access | Times Cited: 6
Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases
Teodoro Jerves Serrano, Jessica I. Gold, James A. Cooper, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1465-1465
Open Access | Times Cited: 5
The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents
Simona Di Martino, Maria De Rosa
Topics in Current Chemistry (2024) Vol. 382, Iss. 4
Closed Access | Times Cited: 4
Emerging biomarkers in Gaucher disease
Danielle M Luettel, Márcia R. Terluk, Jaehyeok Roh, et al.
Advances in clinical chemistry (2025), pp. 1-56
Closed Access
Obstacles to Early Diagnosis of Gaucher Disease
Samantha Nishimura, Charis Ma, Ellen Sidransky, et al.
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 93-101
Open Access
Development of Selective Nanomolar Cyclic Peptide Ligands as GBA1 Enzyme Stabilizers
Rebecca E. Katzy, Renier H. P. van Neer, Maria J. Ferraz, et al.
RSC Chemical Biology (2025)
Open Access
A Multi-Omics-Empowered Framework for Precision Diagnosis and Treatment of Lysosomal Diseases
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyen Quang Thu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101274-101274
Open Access
Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease
John S. Wang, Rebecca L. Koch, Daniel Kenney‐Jung, et al.
JIMD Reports (2024) Vol. 65, Iss. 5, pp. 313-322
Open Access | Times Cited: 2
Gaucher Disease: A Glance from a Medicinal Chemistry Perspective
Filippo Prencipe, Chiara Barzan, Chiara Savian, et al.
ChemMedChem (2024) Vol. 19, Iss. 10
Closed Access | Times Cited: 1
Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience
Andrea Duminuco, M Fazio, Stephanie Grasso, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 11, pp. 1105-1110
Open Access | Times Cited: 3
DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia
Joseph P. Dewulf, Nathalie Chevalier, Sandrine Marie, et al.
Molecular Genetics and Metabolism (2023) Vol. 140, Iss. 3, pp. 107712-107712
Open Access | Times Cited: 2
Gaucher’s Disease – current state of knowledge and future perspectives?
Katarzyna Szymańska, Julia Krasnoborska, Sylwia Samojedny, et al.
Journal of Education Health and Sport (2024) Vol. 64, pp. 131-148
Open Access
Enzymes and Their Clinical Applications
Pradeep Kumar Singh, Manikant Tripathi, Prachi Garg, et al.
(2024), pp. 233-256
Closed Access
Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers
Paulina Szymańska-Rożek, Patryk Lipiński, Gražina Kleinotienė, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12021-12021
Open Access
An Overview of Gaucher Disease
Daniela Anahí Méndez-Cobián, Sandra Guzmán-Silahua, Diana García-Hernández, et al.
Diagnostics (2024) Vol. 14, Iss. 24, pp. 2840-2840
Open Access
Doença de Gaucher: uma abordagem diagnóstica, evolução clínica e revisão
Bárbara Pereira Silva, Mariana Araújo E Souza, Catarina Sampaio De Castro, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 5, pp. 21801-21810
Open Access | Times Cited: 1
Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study
Yu‐Nan Huang, Jing‐Yang Huang, WEN-LING LIAO, et al.
In Vivo (2023) Vol. 37, Iss. 5, pp. 2276-2283
Open Access
Gaucher disease: A diagnostic approach, clinical evolution and review
Bárbara Pereira Silva, Mariana Araújo e Souza, Catarina Sampaio de Castro, et al.
Seven Editora eBooks (2023)
Open Access
Doenças de depósito: ocronose, Fabry e Gaucher
Nilton Salles Rosa Neto
Revista Paulista de Reumatologia (2023) Vol. 22, Iss. 2, pp. 38-46
Closed Access
Page 1

Scroll to top